5 Hot Healthcare Stocks To Buy Now

3. Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)

Average 3-month Volume as of December 27: 19.7 million

Number of Hedge Fund Holders: 20

As of November 15, Rahul Sarugaser at Raymond James holds a Market Perform rating on Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) alongside a $2.50 price target.

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) is a specialty chemicals company that develops a platform for cell programming. It is based in Boston, Massachusetts.

A total of 20 hedge funds were long Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) in the third quarter. Their total stake value was $747.9 million.

Follow Ginkgo Bioworks Holdings Inc.